Results 171 to 180 of about 25,773 (228)
Revisiting the Gray Zone in HBeAg-Negative Chronic Hepatitis B: Insights From a Multicenter Liver Biopsy Cohort. [PDF]
Gül Ö +6 more
europepmc +1 more source
HBsAg glycan isomer: a potential circulating biomarker for monitoring cccDNA and predicting virologic response in chronic hepatitis B. [PDF]
Li J +10 more
europepmc +1 more source
Dual HBV cccDNA-linked HiBiT reporter hepatocyte models for screening of candidate cccDNA modulators. [PDF]
Cao J +13 more
europepmc +1 more source
Altered expression of MX2 and SAMD4A in PBMCs predicts early treatment responses in HBeAg-positive chronic hepatitis B patients during Peg-IFN-α therapy. [PDF]
Pang H, Zhang Q, Chen L, Qin B.
europepmc +1 more source
BACKGROUND: Available treatments for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B are associated with poor sustained responses. As a result, nucleoside and nucleotide analogues are typically continued indefinitely, a strategy ...
Patrick Marcellin +2 more
exaly +1 more source

